Expertise and advice on analysing real-world data

Harnessing real-world data to enlarge medical knowledge and address quality of care
illustration-expertise-conseil
Expertise

Effective tools for healthcare professionals

pelyon-accueil-image-expertise
pelyon-accueil-icon-etudes-epidemiologiques

Epidemiological studies

pelyon-accueil-icon-etudes-pharmaco-epidemiologiques

Pharmacoepidemiological studies

pelyon-accueil-icon-evaluations

Assessment

pelyon-accueil-icon-etudes-economiques

Economic studies

pelyon-accueil-icon-assistance-conseil

Methodological assistance and advice

Application fields

pelyon-accueil-icon-qualite-soins
Quality of care
pelyon-accueil-icon-usage-medicament
Therapeutic adherence
pelyon-accueil-icon-adhesion
Drug use
pelyon-accueil-icon-etudes-cout-maladie
Cost of illness study
pelyon-accueil-icon-prise-en-charge
Comparison of treatment strategies

News

First publication for 2021 from the PELyon team

08/01/2021
We are pleased to share with you our 1st publication for 2021: it presents the vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017, estimated from SNDS data. #snds #vaccinationcoverage#rwe #observationalstudy

Last publication for the year 2020 from the PELyon team

31/12/2020
We are pleased to share our latest publication for the year 2020: it is about the study of the incidence of acute pancreatitis, ischemic cardiovascular disease and diabetes in hyperchylomicronemic patients exhibiting familial chylomicronemia syndrome (FCS), or multifactorial chylomicronemia syndrome (MCS), from the linkage between ndividiual hospital data and SNDS…

Best wishes for 2021

22/12/2020
PELyon wishes you all the best for 2021!

We have partnered with healthcare professionals in the pharmaceutical and biomedical industry, healthcare facilities, health authorities, and associations since 2010.

 

Our experience and skills help them to respond appropriately to strategic decisions on healthcare products and programmes including quality of care, adherence, drug use, cost of illness studies, and comparison of treatment strategies.

 

We are a multidisciplinary team made up of doctors, project managers, epidemiologists, biostatisticians and data analysts. Find out more (lien vers Teams).

Our values

Independence

We work on projects with a public health interest and are committed to publishing the scientific results obtained.

Reliability

We meet deadlines and never compromise on the quality of our deliverables.

Integrity

We draw up our protocols and conduct our analyses according to epidemiological best practice and established procedures.

ÉVALUER
les fardeaux économiques et cliniques des maladies
COMPARER
des stratégies de prise en charge
Publications

Experience

The public health value of the results of the studies carried out by PELyon is evidenced by their publication in international peer-reviewed scientific journals.